Arcadia BiosciencesRKDA
13F holders, Q2 2024 (June 30)11holders −2
2new positions
4sold out
$3.15avg. 13F price*
At the end of Q2 2024, 11 institutions reported holding Arcadia Biosciences Inc. (RKDA) in their 13F filings, down 2 from Q1 2024. 2 opened new positions and 4 sold out. The largest holders were Vanguard Group Inc. ($44K), State Street Corp. ($38K) and Tower Research Capital LLC (TRC) ($6K).
- Company
- Arcadia Biosciences Inc.
- CUSIP
- 039014303
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $311 |
| Exits | 4 | $112K |
All 13F filers, Q1 2024 → Q2 2024: 499 shares bought and 52,755 shares sold, net −52,256 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 11 holders
| Vanguard Group Inc. | 0.00% | No change | 14,038 | $44K |
| State Street Corp. | 0.00% | No change | 12,146 | $38K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -52.8% | 1,783 | $6K |
| Morgan Stanley | 0.00% | Add +193.2% | 607 | $2K |
| Osaic Holdings, Inc. | 0.00% | New | 88 | $276 |
| Group One Trading LLC | 0.00% | No change | 18 | $57 |
| Bank of America Corp. | 0.00% | New | 11 | $35 |
| US Bancorp \de | 0.00% | No change | 5 | $16 |
| Oliver Lagore Vanvalin Investment Group | 0.00% | No change | 4 | $13 |
| Harbour Investments, Inc. | 0.00% | No change | 1 | $3 |
| Royal Bank of Canada | 0.00% | No change | 2 | $0 |
"% of holder's portfolio" is RKDA's weight in each manager's 13F, not the share of Arcadia Biosciences Inc. the manager owns.